These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8808221)

  • 1. Effect of treatment with 1.25 and 1.75 mmol/l calcium dialysate on bone mineral density in haemodialysis patients.
    Van der Niepen P; Sennesael J; Louis O; Verbeelen D
    Nephrol Dial Transplant; 1995 Dec; 10(12):2253-8. PubMed ID: 8808221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term dialysis with low-calcium solution (1.0 mmol/L) in CAPD: effects on bone mineral metabolism. Collaborators of the Multicenter Study Group.
    Weinreich T; Ritz E; Passlick-Deetjen J
    Perit Dial Int; 1996; 16(3):260-8. PubMed ID: 8761540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized trial comparing 1.25 mmol/l calcium dialysate to 1.75 mmol/l calcium dialysate in CAPD patients.
    Johnson DW; Rigby RJ; McIntyre HD; Brown A; Freeman J
    Nephrol Dial Transplant; 1996 Jan; 11(1):88-93. PubMed ID: 8649658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal of adynamic bone disease by lowering of dialysate calcium.
    Haris A; Sherrard DJ; Hercz G
    Kidney Int; 2006 Sep; 70(5):931-7. PubMed ID: 16837920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low calcium (1.25 mmol/L) dialysate can normalize relative hypoparathyroidism in CAPD patients with low bone turnover.
    Shigematsu T; Kawaguchi Y; Kubo H; Nakayama M; Kato N; Yamamoto H; Osaka N; Hayakawa H; Ogawa A; Sakai O
    Adv Perit Dial; 1996; 12():250-6. PubMed ID: 8865914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low calcium dialysate and hyperparathyroidism.
    Duncan R; Cochrane T; Bhalla C; Michael J; Richards NT; Adu D
    Perit Dial Int; 1996; 16 Suppl 1():S499-502. PubMed ID: 8728256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Should dialysate calcium concentration be standardised or individualised?
    Lindley EJ
    J Ren Care; 2009 Mar; 35 Suppl 1():101-6. PubMed ID: 19222740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-normal calcium (1.35 mmol/l) dialysate in patients on CAPD: efficient and safe long-term control of plasma calcium, phosphate, and parathyroid hormone.
    Bro S; Brandi L; Olgaard K
    Nephrol Dial Transplant; 1996 Aug; 11(8):1586-91. PubMed ID: 8856216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of salmon calcitonin on bone mineral density and calcium-phosphate metabolism in chronic hemodialysis patients with secondary hyperparathyroidism].
    Matuszkiewicz-Rowińska J; Niemczyk S; Przedlacki J; Puka J; Switalski M; Ostrowski K
    Pol Arch Med Wewn; 2004 Jul; 112(1):797-803. PubMed ID: 15526839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-calcium dialysate as a risk factor for decline in bone mineral density in peritoneal dialysis patients.
    Kang SH; Cho KH; Park JW; Yoon KW; Do JY
    Scand J Urol Nephrol; 2012 Dec; 46(6):454-60. PubMed ID: 22938029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium kinetics and the long-term effects of lowering dialysate calcium concentration.
    Argilés A; Kerr PG; Canaud B; Flavier JL; Mion C
    Kidney Int; 1993 Mar; 43(3):630-40. PubMed ID: 8455362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parathyroid hormone during maintenance dialysis: influence of low calcium dialysate, plasma albumin and age.
    Heaf JG; Løkkegård H
    J Nephrol; 1998; 11(4):203-10. PubMed ID: 9702872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of lowering dialysate calcium concentration on mineral metabolism and hemodynamic parameters in hemodialysis patients.
    Alayoud A; El Kabbaj D; Benyahia M; Asseraji M; Zemraoui N
    Iran J Kidney Dis; 2015 Mar; 9(2):132-7. PubMed ID: 25851292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement of bone and mineral parameters related to adynamic bone disease by diminishing dialysate calcium.
    Spasovski G; Gelev S; Masin-Spasovska J; Selim G; Sikole A; Vanholder R
    Bone; 2007 Oct; 41(4):698-703. PubMed ID: 17643363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hemodialysis with 2.5 mEq/L of calcium in relative hypoparathyroidism: long-term effects on bone mass].
    Sánchez Perales MC; García Cortés MJ; Borrego FJ; Fernández Martínez S; Borrego J; Pérez del Barrio P; Liébana A; Pérez Bañasco V
    Nefrologia; 2000; 20(3):254-61. PubMed ID: 10917002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of CAPD and hemodialysis on parathyroid function.
    Malberti F; Corradi B; Imbasciati E
    Adv Perit Dial; 1996; 12():239-44. PubMed ID: 8865912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone mineral disturbances in patients with chronic kidney disease stage 5 not yet on dialysis.
    Marn Pernat A; Zrimšek M
    Clin Nephrol; 2017 Supplement 1; 88(13):39-43. PubMed ID: 28619127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin D receptor gene polymorphism detected by digestion with Apa I influences the parathyroid response to extracellular calcium in Japanese chronic dialysis patients.
    Yokoyama K; Shigematsu T; Kagami S; Tsukada T; Arai T; Hara S; Yamada A; Kawaguchi Y; Hosoya T
    Nephron; 2001 Nov; 89(3):315-20. PubMed ID: 11598396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term effects on PTH and mineral metabolism of 1.25 versus 1.75 mmol/L dialysate calcium in peritoneal dialysis patients: a meta-analysis.
    Jin L; Zhou J; Shao F; Yang F
    BMC Nephrol; 2019 Jun; 20(1):213. PubMed ID: 31185931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.